Ionic Mechanisms Responsible for the Electrocardiographic Phenotype of the Brugada Syndrome Are Temperature Dependent
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Abstract-The Brugada syndrome is a major cause of sudden death, particularly among young men of Southeast Asian and Japanese origin. The syndrome is characterized electrocardiographically by an ST-segment elevation in V1 through V3 and a rapid polymorphic ventricular tachycardia that can degenerate into ventricular fibrillation. Our group recently linked the disease to mutations in SCN5A, the gene encoding for the ␣ subunit of the cardiac sodium channel. When heterologously expressed in frog oocytes, electrophysiological data recorded from the Thr1620Met missense mutant failed to adequately explain the electrocardiographic phenotype. Therefore, we sought to further characterize the electrophysiology of this mutant. We hypothesized that at more physiological temperatures, the missense mutation may change the gating of the sodium channel such that the net outward current is dramatically augmented during the early phases of the right ventricular action potential. In the present study, we test this hypothesis by expressing Thr1620Met in a mammalian cell line, using the patch-clamp technique to study the currents at 32°C. Our results indicate that Thr1620Met current decay kinetics are faster when compared with the wild type at 32°C. Recovery from inactivation was slower for Thr1620Met at 32°C, and steady-state activation was significantly shifted. Our findings explain the features of the ECG of Brugada patients, illustrate for the first time a cardiac sodium channel mutation of which the arrhythmogenicity is revealed only at temperatures approaching the physiological range, and suggest that some patients may be more at risk during febrile states. (Circ Res. 1999;85:803-809.)
Key Words: Brugada syndrome Ⅲ Na ϩ channel Ⅲ temperature P olymorphic ventricular tachycardia (VT) and ventricular fibrillation (VF) developing in patients with structurally normal hearts accounts for 5% to 12% of the Ͼ300 000 sudden deaths of Americans each year. 1, 2 Approximately half of these are attributed to the Brugada syndrome, a familial disease electrocardiographically characterized by a downsloping ST-segment elevation terminating in a negative T wave in the right precordial leads, an apparent right bundle branch block, 3, 4 and rapid polymorphic VT capable of degenerating to VF. 5, 6 Slightly prolonged H-V intervals are observed in 60% of patients 7 with Brugada syndrome.
Chen et al 8 recently uncovered the first gene defects linked to the Brugada syndrome, identifying different mutations in SCN5A, the cardiac sodium channel gene, in each of the 3 families studied. A frameshift mutation resulted in an inframe stop codon in the pore region of domain III in one family. Because the syndrome has an autosomal dominant pattern of inheritance, the frameshift mutation is likely to result in a decrease in the number of functional channels, which can explain the clinical manifestation of the syndrome. 3, 4 Missense mutations involving a double substitution of arginine at position 1232 by a tryptophan (Arg1232Trp) and the threonine at position 1620 by a methionine (Thr1620Met) were also found. Heterologous expression of these mutant channels in Xenopus oocytes revealed that the Thr1620Met mutation shifts steady-state inactivation of the channels toward more positive potentials and accelerates reactivation, whereas Arg1232Trp did not produce these effects and is thought to be a rare polymorphism. The electrophysiological profile reported for this mutant at room temperature does not adequately explain the ECG signature of the Brugada syndrome, however. We hypothesized that, at more physiological temperatures, the missense mutation may accelerate the decay of the sodium current, thus leaving the large transient outward current normally present in right ventricular epicardium unopposed. To test this hypothesis, we studied the kinetics of the current at 32°C using the patchclamp technique.
Materials and Methods
The coding sequence of hH1a wild type (WT) was cloned in the pGEM-3 (Promega) expression vector, 8, 9 and the Thr1620Met mutation was produced by site-directed mutagenesis as previously described. 10, 11 The clones were then cut out of pGEM-3 by restriction digest and ligated in pcDNA3.1 (Invitrogen) for expression in mammalian cells. Cells were transfected using the Ca 2ϩ phosphate precipitation method, as previously described. 12 The cells were grown in a polylysine-coated 35-mm culture dish and placed in a heating chamber for electrophysiological measurements (Medical Systems). For patch-clamp experiments, the bath solution contained (in mmol/L) KCl 2, NaCl 150, CaCl 2 1.5, MgCl 2 1, glucose 10, and tetraethylammonium 5, at pH 7.2 (NaOH). The pipette solution contained (in mmol/L) NaCl 35, HEPES 10, EGTA 10, and CsF 105, at pH 7.4 (CsOH) and 309 mosm (sucrose). Micropipettes were drawn from Corning 7052 glass tubing, and microelectrode resistance varied between 0.8 and 1.4 m⍀ when measured in the extracellular solution. Capacitance and series resistances were adjusted to obtain minimal contribution of the capacitive transients. A 70% to 80% compensation of the series resistance was usually achieved without ringing. Currents were recorded with an Axopatch 200A amplifier (Axon Instruments) and digitally stored on the hard disk of an IBM-compatible computer. Analysis was done with the Axon PCLAMP V.7 suite of software (Axon Instruments). Where indicated, the fit to a Boltzmann distribution function was obtained by fitting the data to 1/[1ϩe (Vm-V0.5)/k ], where V m represents the membrane potential, V 0.5 the midpoint of activation, and k the slope factor. The temperature sensitivity coefficient Q 10 was obtained by the expression ln(Q 10 )ϭ 10/⌬Tϫln( I / F ), where T, I , and F represent the temperature and the time constant values at the initial and final temperatures, respectively. Statistical significance was determined using ANOVA or paired Student t test.
Cardiac Action Potential (AP) Modeling
We simulated endocardial, left ventricular epicardial, and right ventricular epicardial APs using a modified version of the Luo-Rudy 2 (phase 2) model. 13, 14 To obtain realistic APs of the right epicardium, we made the following minor changes:
(1) The model of the transient inward potassium current was incorporated into the Luo-Rudy 2 model (see Appendix for the model expressions). Activation of this current is relatively fast, with time to peak of 1.7 ms at ϩ10 mV; the steady-state activation curve is sigmoid, with V 1/2 ϭϪ4 mV (3 activation gates) and a slope of 11.5 mV. The inactivation time constant is 10 ms over the voltage range above Ϫ20 mV (thresholdϭϪ30 mV), and the reactivation time constant is 67 ms at Ϫ80 mV (but 450 ms at Ϫ50 mV). Maximal conductance of I to (G Ito ) was set to 0 for endocardial AP, 0.5 for left ventricular epicardial AP, and 1.1 for right ventricular epicardial AP.
(2) The maximal conductance of I CaL was decreased by 20% to 50% in epicardial models to obtain realistic durations of simulated APs.
(3) To reproduce faster current decay for Thr1620Met mutant as compared with the WT sodium channel, we multiplied both rate constants for inactivation gate h (␣ h and ␤ h ) by a factor of 2, which leaves steady-state inactivation characteristics unchanged. The faster inactivation of I Na resulted in a 32% smaller peak current during upstroke of AP.
Parameters of the model assume that the APs are simulated at the normal body temperature of 37°C. The effects of a faster rate of I Na decay were tested using a simple cable model (1-cm cable, 0.01-cm space steps) to account for the significant electrotonic load on the upstroke of the AP during propagation. Only APs simulated in the center of the cable are shown in this article.
The differential equations were solved numerically using the second-order Runge-Kutta method for time derivatives (time steps of Յ10 s) and the Crank-Nicholson method (the average of the second central difference at time t and at time tϩ⌬t) for space derivatives (space steps of 0.1 cm).
Results
Recordings of macroscopic sodium currents at physiological temperatures are technically challenging. To avoid changes in the kinetics of the current or its voltage relationship due to modified solutions and to minimize errors due to uncompensated series resistance, the experiments used for the statistical analysis were done at 22°C and 32°C. We then routinely tested at higher temperatures, on cells transfected with lower amounts of cDNA and expressing low amplitude currents, the predictions from the experiments at lower temperature. Figure 1 shows whole-cell currents recorded 2 days posttransfection using low-resistance patch-clamp electrodes (0.6 to 1.0 M⍀). The current waveforms and current-voltage relations (IVRs) were similar in WT (nϭ5) and Thr1620Met (nϭ4) at 22°C. At 32°C, the activation and the decay of I Na was faster for Thr1620Met ( Figure 1A ) resulting in a steeper IVR ( Figure 1B ) and a peak of IVR 10 mV more positive when compared with WT (nϭ6). In the experiments shown, the voltage errors due to uncompensated series resistance at 32°C were 0.4 and 0.9 mV for WT and Thr1620Met, respectively, as estimated from the capacitive artifacts. . Whole-cell current for WT and Brugada syndrome mutant (Thr1620Met) in transiently transfected TSA201 cells at room temperature (22°C) and 32°C. A, Location of the missense mutations Arg1232Trp (R1232W) and Thr1620Met (T1620M) previously described by Chen et al. 8 Shown are current recordings obtained at different test potentials from Ϫ70 to Ϫ25 mV (32°C) and Ϫ65 to Ϫ20 (22°C) in increments of 5 mV from a holding potential of Ϫ120 mV for 4 representative cells. B, Normalized peak IVRs for the WT channels (f) and Thr1620Met mutants (F) at 22°C and 32°C (Ⅺ and E) from 4 to 6 different cells at each temperature (see text).
To elucidate the basis for the shift of IVR, we examined the temperature dependence of steady-state activation and inactivation (Figure 2 ). At 22°C, we observed no significant difference between the mid-activation potential for WT (Ϫ43.9Ϯ0.8 mV) and Thr1620Met (Ϫ39Ϯ4 mV) (Boltzmann function fit, Figure 2A ). At 32°C, steady-state activation for Thr1620Met was significantly shifted toward more positive potentials when compared with WT (PϽ0.001), with mid-potential values of Ϫ38.8Ϯ0.4 mV and Ϫ49.5Ϯ0.4 mV, respectively, and was less sensitive than WT to changes of membrane potential with slope factors (k) of 5.4Ϯ0.4 mV and 6.8Ϯ0.4 mV, respectively (PϽ0.05). Steady-state inactivation protocols ( Figure 2B ) revealed no significant differences between WT and Thr1620Met at 22°C and 32°C with halfinactivation voltages, as follows: Ϫ91.5Ϯ0.1 mV and Ϫ91.9Ϯ0.2 mV (22°C) and Ϫ87.1Ϯ0.2 mV and Ϫ86Ϯ0.2 mV (32°C) for WT and Thr1620Met, respectively ( Figure 2C ).
We next looked for changes in the current kinetics of I Na ( Figure 3 ) in a range of potentials encompassing the plateau of the AP and fitted the decay of the current to a sum of 2 exponentials. The fast component accounted for 87Ϯ3% and 83Ϯ5% (WT) and 88Ϯ4% and 90Ϯ3% (Thr1620Met) of the total amplitude of the current at 22°C and 32°C, respectively. The time constant of the fast component () of the current decay was similar for WT and Thr1620Met at 22°C betweenϪ50 and 20 mV, but significantly faster for Thr1620Met at 32°C ( Figure  3B ). At a potential of 10 mV, I Na fully inactivated 4 ms sooner in Thr1620Met than in WT ( Figure 3A) .
To predict the changes in the decay of the sodium current in more physiological conditions, we did a set of experiments at temperatures between 35°C and 42°C and a holding potential of Ϫ80 mV. In this set of experiments, the amount of cDNA used for transfection was reduced by 75%, yielding currents with maximal amplitudes between 1 and 2 nA, filtering of the signal was decreased to 10 kHz, and acquisition was increased to 50 kHz to minimize aliasing caused by bandwidth limitations. Figure 4 shows that the decay of the Thr1620Met current is more rapid than WT in physiological conditions, as predicted by the experiments at 32°C. We found Q 10 values of 1.2 and 2.3 for WT and Thr1620Met, respectively, for the current decay at 0 mV. and Thr1620Met (circles) at 20°C ( f, F) and 32°C (Ⅺ, E). A, Chord conductance was calculated using the ratio of the current to the electromotive for potential 6 individual IVRs as described in Figure  1 . The data were normalized to their respective maximal values, averaged, and plotted against the test potential. Lines represent fit of the data to a Boltzmann distribution function. B, Steady-state inactivation. A conditioning pulse of 450 ms at potentials between Ϫ140 and Ϫ50 mV was applied from a holding potential of Ϫ110 mV to inactivate the channels before a 40-ms test pulse to 15 mV. Representative current recordings for the 2 channels are shown for each temperature. All measurements were made after a minimal time of 20 minutes after rupture of the patch (whole cell) to minimize the contribution of time-dependent shifts of the steady-state gating parameter measurements. C, Peak current amplitudes, as measured in panel B, were normalized to their respective maximal values and plotted against the conditioning pulse amplitude. Data from 6 different cells were averaged and fitted to a Boltzmann distribution function (lines). Current decay for WT (squares) and Thr1620Met (circles) at 22°C ( f, F) and 32°C (Ⅺ, E). A, Representative current recordings elicited by a 20-ms depolarizing pulse to a test potential of 10 mV from a holding potential of Ϫ140 mV were normalized to the peak inward current and superimposed. B, Current decay at different test potentials were fitted by a sum of 2 exponentials, and the time constant of the fast (dominant) component was plotted against test potentials between Ϫ50 and 20 mV for both recording conditions. *PϽ0.05, **PϽ0.01, and ***PϽ0.001 using ANOVA (nϭ6).
We measured the rate of recovery of I Na by varying the interpulse interval of twin pulses to 0 mV from a holding potential of Ϫ110 mV ( Figure 5 ). At 22°C, recovery was slightly faster for Thr1620Met (ϭ23.1Ϯ0.4 and 17.4Ϯ0.2 ms for WT and Thr1620Met, respectively). At 32°C, was much slower for Thr1620Met when compared with WT. A double exponential fit to the data yielded time constants of 1.1Ϯ0.1 (84%) and 3.7Ϯ0.6 (16%), 4.8Ϯ0.3 (90%), and 48Ϯ5 (10%) ms for WT and Thr1620Met, respectively. The data of Chen et al 8 showed a convergence of recovery kinetics at Ϫ110 mV. Our data suggested that this convergence does not exist at 32°C. We therefore checked to see whether a slowing of recovery at Ϫ80 mV could be observed at 37°C in 3 cells. Figure 6 shows that recovery of WT current was 93% complete after 60 ms. By contrast, Thr1620Met currents were slower to recover, as expected from the measurements at 32°C, with still 95% of channels available after 100 ms.
To gain more insight into the arrhythmogenic effects of a faster decay of the sodium current (I Na ), we simulated APs from the endocardium, epicardium of the left ventricle, and epicardium of the right ventricle, which is known to exhibit a prominent transient outward current I to in several species including human. 15 In our simulation (Figure 7) , the faster inactivation of I Na increased the net outward current and lowered the voltage level at the end of phase 1 ( Figure 7B and 7C, notches) with little effect on the configuration of the other phases of the endocardial and left epicardial APs. In the right ventricular epicardium, however, the acceleration of the I Na decay brings this voltage below the calcium current (I CaL ) threshold, thus eliminating the dome and triggering all-or-none repolarization ( Figure 7C ).
Discussion
Our data suggest that the threonine at position 1620 in the coding sequence of SCN5A is an important determinant of the temperature sensitivity of the human cardiac sodium channel. During excitation, the inward sodium current is opposed by the transient outward I to . As I Na decays, the relative contribution of I to to the net current gradually increases and creates a notch resulting in the spike-and-dome morphology of the right epicardial AP plateau. 16 -19 At 32°C, the missense mutation Thr1620Met leads to faster decay and slower reactivation of the current. The more rapid decay of I Na would be expected to leave I to unopposed, thus accentuating phase 1 of the AP. The outward shift of current flowing during phase 1 can lead to loss of the AP dome (plateau) as a result of an all-or-none repolarization at the end of phase 1. This phenomenon is observed in cells and tissues displaying a prominent I to , such as right ventricular epicardium, but not those exhibiting a small I to , such as ventricular endocardium. Our AP simulation confirmed this mechanism. Loss of the dome in right ventricular epicardium but not in endocardium creates a transmural voltage gradient that may serve as a basis for the ST-segment elevation observed clinically and for aberrations in the J wave of the ECG. The resulting transepicardial and transmural dispersion of repolarization can also give rise to phase 2 reentrant extrasystoles capable of precipitating a rapid polymorphic VT/VF, the reentrant arrhythmias responsible for sudden death in the Brugada syndrome. 3,4,20 -22 Our simulation also led to another interesting prediction. Because we wanted to alter the model minimally, we only increased the inactivation rate of I Na with no modifications of the activation kinetics. This resulted in a 32% decrease in the amplitude of the peak sodium current. We initially expected this decrease to reduce the upstroke velocity of the AP and the activation of I to and, ultimately, limit the AP plateau depression. Our simulation suggests that the amplitude of I to is not very sensitive to small variation in the AP upstroke rate. Therefore, reduction of I Na density or acceleration of the inactivation is likely to be very effective in modulating phase 1 by leaving the fully activated I to unopposed.
We observed a 10-mV shift in steady-state activation. Our measurements of the maximal current are accurate within 1 mV of the voltage imposed in the range 6 to 9 nA at 32°C. Therefore, the voltage shift cannot be attributed to uncompensated series resistance. Clinically, this10-mV positive shift of steady-state activation would be expected to raise the activation threshold and thus lead to a mild slowing of conduction. This change in excitability may be responsible for the small H-V interval prolongation and right bundle branch block observed in many patients with the Brugada syndrome. [5] [6] [7] WT and Thr1620Met channels displayed similar steadystate inactivation curves at all temperatures studied. This finding contrasts with the results of Chen et al, 8 possibly because of differences in expression systems (Xenopus oocytes versus HEK cells) and/or specific protocols. It is noteworthy that whole-cell measurements of I Na produce a time-dependent shift of the steady-state inactivation parameters, 23 which is not observed with the agar cushioned 2-electrode voltage-clamp technique applied on frog oocytes. We routinely checked for time-dependent shifts in the mid- Temperature dependence of the decay time constant for the WT ( f ) and Thr1620Met mutant Na ϩ channels (F). Cells were maintained at Ϫ80 mV and pulsed at 0 mV for 10 ms at temperatures between 22°C and 42°C. Current decay values were fitted by a sum of 2 exponential functions. Fast time constant was plotted against the temperature (log scale) for WT and Thr1620Met. In experiments on Thr1620Met, the fast component accounted for Ͼ80% of the current decay in all cells. In experiments on WT, the fast component had a wide range of amplitudes (from 53% to 85%), and only cells displaying a fast component accounting for Ͼ80% of the total amplitude (nϭ6/16) were plotted and used for the extrapolation. Our results therefore underestimate the differences in the current kinetics between WT and Thr1620Met. Each symbol represents a different cell. Data were fitted to a linear regression (lines), with slopes of Ϫ0.46 and Ϫ1.32 for WT and Thr1620Met, respectively.
potential of steady-state inactivation (V 0.5 ) and obtained rates of Ϫ0.42Ϯ0.05 mV/min (nϭ3) and Ϫ0.27Ϯ0.02 mV/min (nϭ4) for WT and Thr1620Met, respectively, at 32°C and Ϫ0.13Ϯ0.08 mV/min (nϭ3) and Ϫ0.11Ϯ0.15 mV/min (nϭ3), respectively, at room temperature. The rates were more rapid during the first 8 to 10 minutes and then remained stable below 0.05 mV/min in all the experiments. Most of the data were obtained after 20 minutes in whole-cell configuration. Therefore, our measurements of V 0.5 are off by 6 to 8 and 2 to 3 mV at 32°C and room temperature, respectively, when compared with the initial midpotential. This may have contributed to the disparate results of the 2 studies.
Our data demonstrate a faster decay of the sodium channel but slower recovery from inactivation for the Thr1620Met mutant at physiological temperature(s). Therefore, the channels are likely to spend more time in the inactivated states, suggesting that the mutation has a stabilizing effect on inactivation of the channel. This is opposite to the effects of mutations observed in the LQT3 form of long QT syndrome, 24 in which a late sodium current is amplified because of destabilized (less absorbent) inactivated states. 10, 25, 26 Given the location of the Thr1620Met mutation in a region strongly involved in the activation-inactivation coupling, [27] [28] [29] [30] [31] we speculate that the effects may be the result of changes in activation and/or deactivation altering this coupling. The exact mechanism for the acceleration of the current decay remains to be established by an in-depth biophysical study of the single-channel behavior of the Thr1620Met mutant.
To our knowledge, this is the first report of a cardiac sodium channel mutation involved in a genetic disease that reveals its arrhythmogenic potential primarily at temperatures approaching the physiological range. The results suggest caution in the interpretation of data obtained from heterologous expression systems at room temperature. 32°C (Ⅺ, E) . A, Double 20-millisecond pulse protocol at 0 mV with varying interpulse duration (⌬t) at a recovery potential of Ϫ110 mV (holding) was used to assess the recovery from fast inactivation. The pulse was applied at a frequency of 0.2 seconds to avoid accumulation of channels in the inactivated states. Current recordings were normalized to the peak inward current during the first pulse and presented for each temperature. Different time increments were tested to obtain the best resolution for the envelope of currents as shown from recordings of WT and Thr1620Met currents during the experiments at 22°C. B, Ratio of the peak current obtained during the test (second) pulse to the peak current recorded during the conditioning pulse was plotted as a function of the recovery interval for each experimental condition. Data from 6 different cells were averaged and fitted to the sum of 2 exponentials (line). 
